评估肌酸 administration 在毒引起的心肌功能障碍的治疗效果
1Department of Intensive Care Unit, The Affiliated Lihuili Hospital of Ningbo University, Ningbo, Zhejiang Province, China.
Medicine
|July 9, 2025
概括
肌酸 (CP) 给药改善了败血症诱导的心肌功能障碍 (SIMD) 患者的心脏功能和存活率. CP增强了氧气输送和全身输液,减少了机械通风需求和ICU停留时间.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 生物化学 生物化学
背景情况:
- 败血症诱导的心肌功能障碍 (SIMD) 是败血症的一个严重并发症.
- 肌酸 (CP) 在细胞能量代谢中起着至关重要的作用.
- 在SIMD中CP的治疗潜力需要进一步研究.
研究的目的:
- 调查肌酸 (CP) 在治疗败血症诱导的心肌功能障碍 (SIMD) 的疗效.
- 评估CP对心脏功能,全身输液和SIMD患者临床结果的影响.
主要方法:
- 对572名SIMD患者的回顾性分析,分为观察 (CP组) 和对照组.
- 收集的人口,临床和生化数据,包括血管活性输液评分 (VIS),乳酸,NT-proBNP,cTnI和CO2差距 (GAP) 参数.
- 评估了28天的生存率,输出管的速度,机械通风的持续时间和ICU停留时间.
主要成果:
- 在24小时内,CP组的NT-proBNP和GAP显著改善.
- 在72小时后,CP组表现出优异的VIS,乳酸,NT-proBNP,GAP和GAP比率.
- 脑膜炎组的28天生存率和输出管率显著更高,机械通风和ICU停留减少.
结论:
- 持续的CP给药 (超过3天) 会增强SIMD患者的氧气输送和全身 perfusion.
- 在SIMD中,CP改善心脏功能,并提供心脏保护.
- 在SIMD中,CP治疗与改善生存率和减少重症监护资源利用率有关.
更多相关视频
相关概念视频
Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
349
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
349
Heart Failure Drugs: Inotropic Agents
739
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
739
Muscle Recovery and Fatigue
2.5K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.5K
Cardiopulmonary Resuscitation IV: Pharmacological Management
81
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
81
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32


